Rainmed Medical Limited (HK:2297)
:2297
Want to see HK:2297 full AI Analyst Report?
Total Valuation
Rainmed Medical Limited has a market cap or net worth of HK$371.36M. The enterprise value is HK$280.35M.
Market CapHK$371.36M
Enterprise ValueHK$280.35M
Share Statistics
Rainmed Medical Limited has 1,401,358,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,401,358,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Rainmed Medical Limited’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -20.67%.
Return on Equity (ROE)-0.22
Return on Assets (ROA)-0.14
Return on Invested Capital (ROIC)-20.67%
Return on Capital Employed (ROCE)-0.22
Revenue Per Employee71.02K
Profits Per Employee-278.10K
Employee Count270
Asset Turnover0.04
Inventory Turnover0.89
Valuation Ratios
The current PE Ratio of Rainmed Medical Limited is ―. Rainmed Medical Limited’s PEG ratio is 0.10.
PE Ratio―
PS Ratio16.34
PB Ratio0.88
Price to Fair Value0.88
Price to FCF-3.93
Price to Operating Cash Flow-3.91
PEG Ratio0.10
Income Statement
In the last 12 months, Rainmed Medical Limited had revenue of 19.18M and earned -77.08M in profits. Earnings per share was -0.06.
Revenue19.18M
Gross Profit9.04M
Operating Income-79.22M
Pretax Income-79.44M
Net Income-77.08M
EBITDA-67.39M
Earnings Per Share (EPS)-0.06
Cash Flow
In the last 12 months, operating cash flow was -81.93M and capital expenditures -3.71M, giving a free cash flow of -85.64M billion.
Operating Cash Flow-81.93M
Free Cash Flow-85.64M
Free Cash Flow per Share-0.06
Dividends & Yields
Rainmed Medical Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.74
52-Week Price Change31.19%
50-Day Moving Average0.24
200-Day Moving Average0.28
Relative Strength Index (RSI)62.83
Average Volume (3m)3.71M
Important Dates
Rainmed Medical Limited upcoming earnings date is Aug 27, 2026, TBA (Confirmed).
Last Earnings DateMar 31, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
Rainmed Medical Limited as a current ratio of 1.13, with Debt / Equity ratio of 6.94%
Current Ratio1.13
Quick Ratio1.07
Debt to Market Cap0.08
Net Debt to EBITDA-0.15
Interest Coverage Ratio-110.03
Taxes
In the past 12 months, Rainmed Medical Limited has paid -37.00K in taxes.
Income Tax-37.00K
Effective Tax Rate<0.01
Enterprise Valuation
Rainmed Medical Limited EV to EBITDA ratio is -4.80, with an EV/FCF ratio of -4.06.
EV to Sales16.88
EV to EBITDA-4.80
EV to Free Cash Flow-4.06
EV to Operating Cash Flow-4.24
Balance Sheet
Rainmed Medical Limited has HK$153.35M in cash and marketable securities with HK$24.83M in debt, giving a net cash position of HK$128.52M billion.
Cash & Marketable SecuritiesHK$153.35M
Total DebtHK$24.83M
Net CashHK$128.52M
Net Cash Per ShareHK$0.09
Tangible Book Value Per ShareHK$0.25
Margins
Gross margin is 47.14%, with operating margin of -413.13%, and net profit margin of -401.98%.
Gross Margin47.14%
Operating Margin-413.13%
Pretax Margin-414.28%
Net Profit Margin-401.98%
EBITDA Margin-351.43%
EBIT Margin-390.38%
Analyst Forecast
The average price target for Rainmed Medical Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-51.87%
EPS Growth Forecast38.90%